Cormorant Asset Management’s HTG Molecular Diagnostics, Inc. Common Stock HTGM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-1,130
| Closed | -$541K | – | 69 |
|
|
2017
Q2 | $541K | Hold |
1,130
| – | – | 0.09% | 63 |
|
|
2017
Q1 | $1.41M | Hold |
1,130
| – | – | 0.2% | 66 |
|
|
2016
Q4 | $456K | Hold |
1,130
| – | – | 0.06% | 70 |
|
|
2016
Q3 | $472K | Hold |
1,130
| – | – | 0.05% | 75 |
|
|
2016
Q2 | $529K | Buy |
1,130
+13
| +1% | +$6.09K | 0.08% | 74 |
|
|
2016
Q1 | $577K | Hold |
1,117
| – | – | 0.09% | 75 |
|
|
2015
Q4 | $876K | Hold |
1,117
| – | – | 0.1% | 70 |
|
|
2015
Q3 | $1.53M | Hold |
1,117
| – | – | 0.24% | 67 |
|
|
2015
Q2 | $2.24M | Buy |
+1,117
| New | +$2.24M | 0.3% | 60 |
|